Ampa

United States · Healthtech · Hardware · Consumer

Ampa builds a portable, camera-guided transcranial magnetic stimulation system for clinicians providing depression care.

Portable equipment for clinical practice

Ampa develops Ampa One, a transcranial magnetic stimulation system for mental-health clinics. The product combines portable equipment, a handheld coil and camera-guided targeting so clinicians can deliver brain-stimulation treatment within their existing practices. Its subscription model gives clinics a route to offering TMS without buying a large fixed installation.

A clinician-facing neurotechnology business

The company’s work centers on making the equipment and operating workflow easier for clinical teams to adopt. Ampa describes its FDA-cleared system as a depression-treatment platform. It sells to care providers, with the hardware and guidance tools supporting treatment delivery by licensed professionals.

Funding history

1 round · 0 with disclosed amounts
AnnouncedRoundAmountInvestors
UndisclosedUndisclosedJake Collective — Role not disclosedMorningside Ventures — Role not disclosedNeta Foundation — Role not disclosedTim Ferriss — Role not disclosedTrimera Capital — Role not disclosed
Sourcesampahealth.com ↗prnewswire.com ↗